Antonio Mulero‐Sánchez
Impact in
-
- Galectins and Cancer Biology
Papers in
-
- Protein Tyrosine Phosphatases 2
- CRISPR and Genetic Engineering 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Degradation and Inhibitors 1
- Oncology 2
- PARP inhibition in cancer therapy 1
- Co-authors
- René Bernards (4 shared papers)Cor Lieftink (3 shared papers)Sara Mainardi (3 shared papers)Astrid Bosma (3 shared papers)Alberto Villanueva (1 shared paper)Samuel Gonçalves-Ribeiro (1 shared paper)Paul Krimpenfort (1 shared paper)Giovanni Germano (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Life Science Alliance (1 paper)Molecular Oncology (1 paper)Nature Medicine (1 paper)ESMO Open (1 paper)
- Partner nations
- NetherlandsSwitzerlandSpain
In The Last Decade
Antonio Mulero‐Sánchez
6 papers receiving 252 citations
Peers
Comparison fields: 5 of 30
- Toxicology 17
- Immunology 72
- Oncology 91
- Molecular Biology 226
- Cancer Research 24
Countries citing papers authored by Antonio Mulero‐Sánchez
This map shows the geographic impact of Antonio Mulero‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Mulero‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Mulero‐Sánchez more than expected).
Fields of papers citing papers by Antonio Mulero‐Sánchez
This network shows the impact of papers produced by Antonio Mulero‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Mulero‐Sánchez. The network helps show where Antonio Mulero‐Sánchez may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Mulero‐Sánchez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 226 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 8 | |
| 4 | 2019 | 7 | |
| 5 | 2023 | 2 | |
| 6 | 2025 | 1 |
About Antonio Mulero‐Sánchez
Antonio Mulero‐Sánchez is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine and Cancer Research, having authored 6 papers that have together received 255 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (2 papers), CRISPR and Genetic Engineering (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Advanced Breast Cancer Therapies (1 paper), Cancer Genomics and Diagnostics (1 paper), Protein Degradation and Inhibitors (1 paper), PARP inhibition in cancer therapy (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Toxicology (17 citations), Immunology (72 citations), Oncology (91 citations), Molecular Biology (226 citations) and Cancer Research (24 citations). Antonio Mulero‐Sánchez has collaborated with scholars based in Netherlands, Switzerland and Spain. Frequent co-authors include René Bernards, Cor Lieftink, Sara Mainardi, Astrid Bosma, Alberto Villanueva, Samuel Gonçalves-Ribeiro, Paul Krimpenfort, Giovanni Germano, Alberto Bardelli and Anirudh Prahallad. Their work appears in journals such as Annals of Oncology, Life Science Alliance, Molecular Oncology, Nature Medicine and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.